CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award ...
Artificial intelligence (AI)-based algorithms that use electrocardiogram (ECG) data have high accuracy in predicting ...
PH is a progressive, life-threatening pulmonary vascular disease estimated to affect up to 1% of the global population. 1 It is often difficult to diagnose 2 due to non-specific early symptoms, such ...
This single-centre prospective study included 1,490 patients who had symptoms suggestive of ACS but without an ST elevation on the initial ECG. AI-based ECG interpretation ruled out occlusive MI in 1, ...
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that three abstracts ...
An artificial intelligence (AI) algorithm paired with the single-lead electrocardiogram (ECG) sensors on a smartwatch accurately diagnosed structural heart diseases, such as weakened pumping ability, ...
Clinicians rely daily on electrocardiograms (ECG) to detect common cardiovascular conditions, but accurate diagnoses require high levels of expertise. In a new study that reviewed nearly 1 million ...
A quick heart trace taken during a warm-up trot could identify racehorses at risk of cardiac arrhythmias during ...
Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology - the first of which is now commercially available “At Anumana, we are committed to developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results